ASX/NTI (ASX/NTI)

Australian Securities Exchange: ASX/NTI · AUD

A$0.02

-0.00 (-5.6%)· Recorded snapshot

Market cap	27.5M
Revenue (ttm)	4.7M
Net income (ttm)	-6.5M
EPS (ttm)	-A$0.01
Shares out	1.6B
Volume	632,078
Beta	0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.7M
Net income (ttm): -6.5M
EPS (ttm): -A$0.01
Market cap: 27.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-366.7

P25 -108P50 -50.6P75 1.1

ROIC-231.8

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/NTI indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

AUD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-03
Enterprise value	AUD 25.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2016
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000NTI9
Last earnings date	2026-02-24
Last refreshed	2026-10-29
Market cap	AUD 27.5M
Next earnings date	2026-11-03
Price	AUD 0.02
Price currency	AUD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-29
Symbol	asx/NTI
Website	https://neurotechinternational.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-32.54%
EV/Sales	5.3x
FCF / EV yield	-16.84%
FCF yield	-15.38%
Industry forward P/E	28.51x
P/B ratio	44.95x
P/S ratio	5.8x
Price / tangible book value	44.95x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-139.65%
EBITDA margin	-139.64%
Gross margin	100%
Operating margin	-139.65%
Pretax margin	-138.11%
Profit margin	-138.11%
ROA	-138.02%
ROA (5Y)	-91.16%
ROCE	-1,081.82%
ROE	-366.75%
ROE (5Y)	-197.9%
ROIC	-231.77%
SBC / revenue	12.93%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	93.68%
Gross profit growth (Q)	-47.53%
Gross profit growth 3Y	58.26%
Gross profit growth 5Y	83.64%
Net income growth years	1
Revenue growth	93.68%
Revenue growth 10Y	36.22%
Revenue growth 3Y	58.26%
Revenue growth 5Y	87.12%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 289
EBIT	AUD -6.6M
EBITDA	AUD -6.6M
EPS	AUD -0.01
FCF per share	AUD -0.00
Financing cash flow	AUD 3.6M
Free cash flow	AUD -4.2M
Free cash flow minus SBC	AUD -4.8M
Gross profit	AUD 4.7M
Net cash flow	AUD -644,553
Net income	AUD -6.5M
Operating cash flow minus SBC	AUD -4.8M
Operating income	AUD -6.6M
Revenue	AUD 4.7M
Stock-based compensation	AUD 612,216

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-30.92
Book value per share	AUD 0.00
Debt / equity	0
Long-term assets	AUD 0
Long-term liabilities	AUD 0
Net cash (debt)	AUD 2.4M
Net cash / market cap	8.69%
Net cash growth	-21.27%
Net debt / equity	-3.9
Piotroski F-Score	2
Shareholders' equity	AUD 611,141
Tangible book value	AUD 611,141
Tangible book value per share	AUD 0.00
Total assets	AUD 2.7M
Total cash	AUD 2.4M
Total debt	AUD 0
Total liabilities	AUD 2.1M
WACC	4.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.58
Current assets	AUD 2.7M
Current liabilities	AUD 2.1M
Current ratio	1.29
Net working capital	AUD -1.8M
Quick ratio	1.28
Working capital	AUD 611,141
Working capital turnover	2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-14.11%
Shareholder yield	-14.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.01
1D price change	-5.56%
1M price change	21.43%
1M total return	21.43%
1W price change	-5.56%
1W total return	-5.56%
20-day SMA	AUD 0.02
200-day SMA	AUD 0.01
3Y price change	-72.13%
3Y return CAGR	-34.67%
3Y total return	-72.13%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.02
52-week high date	2026-07-14
52-week low	AUD 0.01
52-week low date	2026-03-23
5Y price change	-69.64%
5Y return CAGR	-21.22%
5Y total return	-69.64%
6M price change	41.67%
6M total return	41.67%
All-time high	AUD 0.56
All-time high date	2016-11-25
All-time low	AUD 0.00
All-time low date	2020-03-27
Average true range (ATR)	AUD 0.00
Average volume	6.4M
Beta (1Y)	0.37
Beta (2Y)	0.12
Beta (5Y)	0.01
Change from 52-week high	-19.05%
Change from 52-week low	70%
Change from all-time high	-96.94%
Change from all-time low	466.67%
Change from open	-5.56%
Day's gap	0%
Dollar volume	AUD 10,745
High price	AUD 0.02
Low price	AUD 0.02
Monthly RSI	40.47
Open price	AUD 0.02
Position in 52-week range	0%
Previous close	AUD 0.02
Price vs 150-day SMA	21.43%
Price vs 20-day SMA	4.29%
Price vs 200-day SMA	23.19%
Price vs 50-day SMA	16.44%
Relative volume	0.1
RSI	54.42
Sharpe ratio	0.42
Sharpe ratio (3Y)	-0.13
Sharpe ratio (5Y)	0.12
Sortino ratio	0.71
Sortino ratio (3Y)	-0.13
Sortino ratio (5Y)	0.25
Volume	632.1K
Weekly RSI	56.06
YTD price change	21.43%
YTD total return	21.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1B
Shares change (QoQ)	24.23%
Shares change (YoY)	14.11%
Shares held by insiders	12.14%
Shares held by institutions	12.95%
Shares outstanding	1.6B

Deeper analysis on ASX/NTI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/NTI report

Is a complete ASX/NTI research report available?

No complete published report is available for asx/NTI (ASX/NTI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/NTI (ASX/NTI)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/NTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/NTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/NTI

Frequently asked questions